Fluoride: Page 57

New emergency preparedness information for dental offices
By DrBicuspid.com staff writers
Guidelines for managing medical emergencies have been updated with new information, offering a list of emergency medications and equipment, for dental providers.
May 2, 2010
Dentist arrested for trying to take drugs to Haiti
By Laird Harrison
Karyl Jean Beauchamp, D.D.S., arrived at the airport in Nashville on April 18 with the best of intentions. In a matter of hours, she expected to be in Haiti dispensing care to some of the neediest patients in the world. But Dr. Beauchamp made a serious mistake in her charity mission.
May 2, 2010
2009 07 13 09 44 04 276 Bottle Pills 70
Iowa may allow dentists to perform Botox procedures
By DrBicuspid.com staff writers
Licensed dentists in Iowa may soon be allowed to perform procedures using Botox and other derma fillers if the use is directly related to the practice of dentistry.
April 6, 2010
Patch more effective than mouthwash on xerostomia
By DrBicuspid.com staff writers
A new time-released, muco-adhesive patch for treating xerostomia and other oral health conditions has been shown to be more effective than a leading oral rinse, according to a new study.
March 21, 2010
Wash. hopes tamper-resistant paper will curb prescription fraud
By DrBicuspid.com staff writers
To curb prescription fraud and abuse, the state of Washington will require all prescriptions to be printed on tamper-resistant paper with ink that changes color when rubbed with a finger starting July 1.
March 4, 2010
Novalar partners with Sanofi to sell OraVerse in Europe
By DrBicuspid.com staff writers
Novalar Pharmaceuticals has entered into an exclusive license and distribution agreement with Sanofi-Aventis Deutschland to offer its vasodilator drug phentolamine mesylate, OraVerse, in Germany beginning in 2011, the companies announced.
March 2, 2010
FDA rejects OraVerse brochure
By DrBicuspid.com staff writers
The U.S. FDA has asked Novalar Pharmaceuticals to stop distributing a patient brochure for the drug OraVerse (phentolamine mesylate), which it markets for reversing the effects of local anesthesia.
February 25, 2010
Judge refuses to dismiss Fosamax case, sets trial
By Reuters Health
NEW YORK (Reuters), Jan 29 - A Manhattan federal judge refused on Friday to dismiss a lawsuit alleging that Merck & Co. Inc.'s osteoporosis drug Fosamax caused jaw damage to an Indiana woman during the nearly eight years she took the pill.
January 28, 2010
2007 07 16 11 33 13 706
Rituximab effective for Sjögren's syndrome
By Reuters Health
NEW YORK (Reuters Health), Jan 26 - Rituximab can improve saliva secretion and other parameters in patients with primary Sjögren's syndrome, researchers report.
January 25, 2010
2007 07 16 11 33 13 706
Oragenics offers probiotic chew for kids
By DrBicuspid.com staff writers
Oragenics has launched EvoraKids, the first probiotic-based, all-natural oral care chewable created to promote oral health for children 3-10 years old. EvoraKids includes Oragenics' patent-pending ProBiora3 technology, specifically formulated for children to help maintain healthy teeth.
January 24, 2010
Black raspberries fuel new oral cancer drug
By DrBicuspid.com staff writers
Regulatory Affairs Associates (RAA) has signed a contract with Ohio State University to manufacture clinical supplies for a new drug designed to prevent oral cancer. The topical gel formulation uses anthocyanins obtained from black raspberries as the active component. Anthocyanins are promising cancer-preventing agents due to their antioxidant and anti-inflammatory properties.
January 19, 2010
NH dentists want MDs' help
By DrBicuspid.com staff writers
Pediatricians should offer more dental services and communities should fluoridate their water, the New Hampshire Dental Society is arguing in a new report, according to the Boston Globe.
January 18, 2010
Previous Page
Page 57 of 61
Next Page